Podcast appearances and mentions of meg tirrell

We've all heard that so-called “ultraprocessed” foods aren't great for us—but why? It turns out scientists are still trying to figure that out. Dr. Sanjay Gupta sits down with his friend and colleague, CNN's Meg Tirrell, to talk about her recent visit to the National Institutes of Health, where researchers are studying the effects of these foods in ways that could shape future food policy and change how we shop.  Learn more about your ad choices. Visit podcastchoices.com/adchoices

Today's show begins at the Supreme Court where the justices appear deeply divided over one of the biggest abortion cases since Roe vs. Wade was overturned. The issue is whether an Idaho abortion ban prevents doctors from performing abortions for women who are having a medical emergency that may not be life-threatening, but is a threat to her health. CNN's Paula Reid and Meg Tirrell join Dana to break everything down.  Learn more about your ad choices. Visit podcastchoices.com/adchoices

It's become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sanjay Gupta turns to his CNN colleague Meg Tirrell for answers, and a little context about the business behind these new medications. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Averages closed negative today but ended the week in the green. Fundstrat's Tom Lee gave his case for why the bulls are currently in control. Barclays' Jason Goldberg breaks down the sharp move higher in JPMorgan shares while looking ahead to next week's earnings reports from the regional banks. It was a busy week of economic macro data and Fedspeak. Ned Davis Research's Alejandra Grindal on what it all means. Krispy Kreme CEO Michael Tattersfield on food and labor costs, plus the state of the consumer. Boeing shares slide after announcing a delivery slowdown and Cowen's Cai Von Rumohr rates the stock impact. Our Pippa Stevens on why California's solar boom may be ending and Meg Tirrell on Catalent's major stock slide. Plus, Jon on the growing importance of technology in education and Morgan on SpaceX's Starship. 

Stocks finished mixed and near worst levels. Vital Knowledge's Adam Crisafulli and Cantor Fitzgerald's Eric Johnston battle out where the market goes from here in a bear versus bull debate. Evercore analyst CJ Muse on why it's a “stock-pickers paradise” in the chips sector. Tilray shares fell today. CEO Irwin Simon discusses the latest quarter and big acquisition. CrowdStrike hosted its first ever government summit. CEO George Kurtz joins from there to talk public/private partnerships in cloud and cybersecurity. Why Weight Watchers soared nearly 60% higher today and our Meg Tirrell discusses the weight loss drug market with the FDA Commissioner Dr. Califf. Plus, former Kansas City Fed President Thomas Hoenig on upcoming inflation data, short seller Brad Lamensdorf on CarMax and our Mackenzie Sigalos on bitcoin's recent rally.

Carlyle Group co-founder and co-chairman David Rubenstein considers how the banking crisis of today compares to that of 2008. In a wide-ranging conversation, he discusses the latest jobs report, the tight labor market, and the Federal Reserve's path forward. Rubenstein shares details from his upcoming new docuseries on PBS, “Iconic America.” A federal judge in Texas suspended the FDA's approval of the abortion pill mifepristone. CNBC's Meg Tirrell reports on the pharmaceutical response to the decision. Plus, ‘The Super Mario Bros. Movie' had a big weekend at the box office, China completed military exercises near Taiwan, and Jon Rahm mastered the Masters.  In this episode:Meg Tirrell, @megtirrellEamon Javers, @EamonJaversAndrew Ross Sorkin, @andrewrsorkinJoe Kernen, @JoeSquawkMelissa Lee, @MelissaLeeCNBCCameron Costa, @CameronCostaNY

Back-to-back positive session for the major averages has the S&P 500 back above 4000. Ariel investments' Charles Bobrinskoy and Evercore's Julian Emanuel on how to position right now. WWE CEO Nick Khan says there has been a “robust response” from potential bidders for the company after Vince McMahon's return and he remains optimistic about legalizing betting on the sport. General Catalyst CEO Hemant Taneja penned an op-ed this week arguing for specific new rules and regulations around AI. He breaks down his case. Morgan Stanley's Keith Weiss has some top picks in the software sector and our Meg Tirrell wraps up her series on the prescription drug crisis with a look the huge shortages of both antibiotics and generic drugs. Plus, Morgan Brennan with a look at tomorrow's inflation data, today.

Antibiotics and generics are in short supply, and it's affecting every demographic in the U.S. CNBC's Senior Science & Health reporter Meg Tirrell does a deep dive into America's prescription drug shortage. In a conversation exclusive to Squawk Pod, Tirrell explores the supply chain disruptions and market failures that are to blame for the shortage. Plus, Joe Kernen and Becky Quick digest Wall Street's headlines: Jamie Dimon's upcoming deposition, the Silicon Valley Bank hearings on Capitol Hill, rising costs of elite education, and an Ice Age-era snack.  In this episode:Meg Tirrell, @megtirrellJoe Kernen, @JoeSquawkBecky Quick, @BeckyQuickKatie Kramer, @Kramer_Katie

Founders Fund was fingered in the days after Silicon Valley Bank's collapse as a possible accelerant for the failure. General Partner Keith Rabois talks why that wasn't the case, why TikTok should be banned in the US and why researchers should not pause AI experimentation. Meanwhile stocks closed near session highs as the averages shook off Tuesday's declines. Axonic Director of Research Peter Cecchini talked the market action and Loop Capital's Anthony Chukumba gave instant reaction to RH's earnings. Jon Fortt walks through why Intel had its best day since November and NBER Director Charles Dallara talks calls for more banking regulation.  Our Kate Rogers reports on former Starbucks CEO Howard Schultz time in front of Congress today and Meg Tirrell analyzes the lack of generic drugs on the market. Plus, Macquarie's Tim Nollen on Q2 opportunities in the communication services sector. 

In the first meeting of a new House committee on U.S. competition with China, lawmakers displayed a rare show of bipartisanship. CNBC's Eamon Javers shares the agenda of the group, from Washington, DC. In New York, Virginia Governor Glenn Youngkin discusses threats from China, including TikTok and foreign buyers of American farmland. Plus, as a Republican leader in a purple state, Youngkin weighs in on the 2024 election. Eli Lilly is cutting the out-of-pocket cost of insulin by 70%. CNBC's Meg Tirrell reports on the price cap for the drugmaker's life saving medication. Rivian's stock is under pressure after a mixed Q4 report, Tesla and Goldman Sachs are delivering new messaging to shareholders on their respective investor days. In this episode:Meg Tirrell, @megtirrellGlenn Youngkin, @GovernorVAEamon Javers, @EamonJaversBecky Quick, @BeckyQuickJoe Kernen, @JoeSquawkAndrew Ross Sorkin, @andrewrsorkinKatie Kramer, @Kramer_Katie

President Biden takes a victory lap during a Virginia speech after the latest data shows the U.S. economy is still growing despite fears of recession. It comes as the White House and House Republicans are at odds over the debt ceiling and budget cuts. Plus, five former Memphis police officers are facing second degree murder charges for the death of Tyre Nichols. Tara Palmieri, Reed Galen, Jen Psaki, Marq Claxton, Charles Coleman, Stephen Gruber-Miller, Cara Fitzpatrick, Meg Tirrell join.

Ukrainian President Volodymyr Zelenskyy says the Russian attack on Kyiv today was an attempt by Putin to “humiliate the U.N. and everything the organization represents.” Cal Perry reports live from Kyiv after Ukraine filed the first war crimes charges against Russian soldiers for what they did in Bucha. Plus, Meg Tirrell on Moderna announcing it asked U.S. regulators to authorize its two dose covid vaccine for kids six months through five-years-old. And Perry Russom has an update following the murder of a 10-year-old girl in Wisconsin after a coroner confirmed her cause of death was a homicide. Also, NYU responds to Taylor Swift fans trying to crash the university's 2022 commencement, where she is set to speak and get an honorary degree.

The CEO of AstraZeneca, Pascal Soriot, joins Meg Tirrell to discuss the companies earnings and its Covid treatments. Plus, Disney beat on earnings and subscriber numbers and the stock is up big. John Hodulik of UBS joins to discuss his bull case. And Brian takes a look at the biggest Congressional stock trades happening lately, and who's making them.

In this episode, Anthony is joined by international bestselling author Ken Follett, for a discussion on his most recent contemporary novel ‘Never' described by The Washington Post as a “cautionary tale of global catastrophe;” shares what inspires him in the creative process; and reveals his favorite protagonist out of the 36 books he has written.  Meg Tirrell, senior health and science reporter for CNBC talks with Anthony about the power of modern medicine; what developments she's most excited by at the moment;  and gives us the latest on Covid-19 and vaccines in the United States. Finally, Peter Smith, co-founder and chief executive of blockchain.com joins Anthony to recall the company's founding journey; their mission and vision of playing the “long game;” and gives his thoughts on US regulation of cryptocurrencies, and what this means for the future. Follow our guests on Twitter: https://twitter.com/KMFolletthttps://twitter.com/megtirrell https://twitter.com/OneMorePeter Subscribe on YouTube: //bit.ly/3ICdZXx Follow us:https://twitter.com/moochfm  https://twitter.com/scaramucci  Sign up for our newsletter at:www.mooch.fm Created & produced by Podcast Partners:www.podcastpartners.com 

Today on What Next TBD: What is going on with little kids' vaccines? Why don't they seem to be a priority for the government or the pharmaceutical companies, while parents are stressed to a breaking point? We discuss with Meg Tirrell, health and science correspondent for CNBC, and co-host of the Readout Loud podcast. Learn more about your ad choices. Visit megaphone.fm/adchoices

Today on What Next TBD: What is going on with little kids' vaccines? Why don't they seem to be a priority for the government or the pharmaceutical companies, while parents are stressed to a breaking point? We discuss with Meg Tirrell, health and science correspondent for CNBC, and co-host of the Readout Loud podcast. Learn more about your ad choices. Visit megaphone.fm/adchoices

Today on What Next TBD: What is going on with little kids' vaccines? Why don't they seem to be a priority for the government or the pharmaceutical companies, while parents are stressed to a breaking point? We discuss with Meg Tirrell, health and science correspondent for CNBC, and co-host of the Readout Loud podcast. Learn more about your ad choices. Visit megaphone.fm/adchoices

Today on What Next TBD: What is going on with little kids' vaccines? Why don't they seem to be a priority for the government or the pharmaceutical companies, while parents are stressed to a breaking point? We discuss with Meg Tirrell, health and science correspondent for CNBC, and co-host of the Readout Loud podcast. Learn more about your ad choices. Visit megaphone.fm/adchoices

Carl Quintanilla, Jim Cramer and David Faber on inflation watch: Markets rise despite data showing consumer prices up 7% in December from a year ago. Cramer offered his perspective on how Fed Chair Jerome Powell is handling inflation in wake of Tuesday's re-confirmation hearing on Capitol Hill. The anchors also reacted to what Domino's CEO Richard Allison told CNBC about how he sees the inflation picture. Also in focus: The financial sector's record run ahead of big bank earnings, Nasdaq coming off its best day in three weeks: Has it bottomed? Dish Network shares jump on reports it is in merger talks with DirecTV, DoorDash CEO Tony Xu joins the board of Facebook parent Meta and Biogen shares tumble on Medicare decided it would only cover the company's Alzheimer's drug under certain conditions. On day three of the J.P. Morgan Healthcare conference, Meg Tirrell interviewed Novartis CEO Vas Narasimhan about everything from its licensing of a COVID drug to Medicare's decision on covering Biogen's Alzheimer's drug.

Carl Quintanilla, Jim Cramer and David Faber explored how investors should navigate a rough start to the week for stocks: The tech sector extending its 2022 sell-off amid rising bond yields. Bitcoin and other cryptocurrencies also continuing to take a hit. Take-Two Interactive was the S&P 500's worst performer after the home of "Grand Theft Auto" announced it has agreed to acquire mobile gaming company Zynga for $9.86 per share in cash and stock, representing a 64% premium to Friday's closing price. Take-Two Chairman & CEO Strauss Zelnick appeared on the program exclusively to discuss the deal. As part of CNBC's coverage of the virtual J.P. Morgan Health Care Conference, Meg Tirrell interviewed Gilead Sciences CEO Daniel O'Day about his company's antiviral "Remdesivir" and how the treatment is faring against the COVID-19 omicron variant. Carl, Jim and David reacted to Wall Street firms' top stock picks for 2022.

President Biden's Covid vaccine mandate hangs in the balance of the Supreme Court. The Supreme Court began hearing oral arguments in two cases involving vaccination requirements with the Court's conservative Chief Justice, John Roberts, stating it is an issue for Congress. The mandates would roughly affect 100 million Americans. CNBC's Kayla Tausche has the latest Washington DC. Six of the president's former Covid advisors are calling for a new national pandemic strategy that would involve adapting to a new normal. Adaptions would include rebuilding public healthcare infrastructure, improving testing, and continued vaccine research. CNBC's Senior Health and Science reporter Meg Tirrell explains what these advisors are calling for. The crisis in Kazakhstan continues to worsen as their authoritarian president ordered the country's security forces to open fire without warning amid a desperate and violent crackdown on protesters. It comes after demonstrations against the government snowballed from anger over a fuel price hike into the most serious unrest the Central Asian nation has faced in decades.

Guy, Dan, and Danny discuss the big market moves of the week (2:55), introduce Ned Michaels, a new member of the RiskReversal family (24:03), and interview CNBC's Meg Tirrell about her documentary “A Race Against COVID-19” (35:24).  ---- See what adding futures can do for you at cmegroup.com/onthetape.  ---- Shoot us an email at OnTheTape@riskreversal.com with any feedback, suggestions, or questions for us to answer on the pod and follow us @OnTheTapePod. We're on social: Follow Dan Nathan @RiskReversal on Twitter Follow @GuyAdami on Twitter Follow Danny Moses @DMoses34 on Twitter Follow us on Instagram @RiskReversalMedia

DarkSide, the hacker group behind the recent Colonial Pipeline ransomware attack, has a business model that’s more familiar than people think, according to New York Times correspondent Andrew Kramer. He discusses the hacker group and describes them as “something like a franchise.” CNBC’s Meg Tirrell reports on Biogen’s Alzheimer’s drug, Aducanumab, as patients await its FDA approval. The FDA will issue the decision by June 7. NBC’s Shaquille Brewster discusses the battle between the Florida governor and the CDC’s cruise ship vaccination regulations. NBC News’ Heidi Przybyla discusses school infrastructure issues as the pandemic exposes the “third world” conditions at some U.S. schools. Przybyla speaks with educators and students on their experiences. Plus, how the JBS ransomware attack affected cattle ranchers, their businesses and the overall food supply.

President Biden has ordered a closer intelligence review of what he said were two equally plausible scenarios of the origins of the Covid-19 pandemic. CNBC’s Meg Tirrell reports. CNBC’s Eamon Javers discusses how Russia and Iran spread misinformation during the Trump administration, according to a Facebook report. Arthur Caplan, director of medical ethics at NYU’s Grossman School Of Medicine, discusses privacy concerns regarding Google’s deal to develop healthcare algorithms. NBC’s Sahil Kapur reports on a potential bipartisan deal on gun reform. Senator John Cornyn (R-Texas) and Senator Chris Murphy (D-Conn.) are working to close the background check loophole. Plus, CNBC’s Scott Cohn reports on the San Jose VTA shooting. The bomb squad is searching the railyard after a gunman killed eight people. This marks 15 mass shootings in a little over two months.

: A source confirmed to NBC news that three researchers from China’s Wuhan Institute of Virology got so sick in November 2019 they needed hospital treatment. Rumors that Covid-19 originated from a lab are now gaining momentum. Eunice Yoon reports. Jamie Metzl, senior fellow at the Atlantic Council, also discusses why it’s important to understand where the Covid-19 virus originated. Only about 2 percent of Japan’s population has been fully vaccinated ahead of Tokyo Olympics. Meg Tirrell discusses why Japan is lagging in the Covid-19 vaccine race. Sen. Amy Klobuchar (D-Minn.) introduced a bill to ban political campaigns from steering online donors into recurring contributions by default. Valerie Castro reports. Plus, there’s been a continuing pile-up of police misconduct cases since George Floyd’s death a year ago. Ylan Mui reports.

Airbnb has announced a major slate of updates to its platform just in time for an expected surge in travel. Airbnb CEO Brian Chesky discussed the update and what he expects from the post-pandemic travel surge. CNBC’s Phil LeBeau also reports airline passenger levels are inching closer to where they were before the pandemic. Moderna said its Covid-19 vaccine was effective in a study of adolescents ages 12 to 17, making it the second shot behind Pfizer’s to demonstrate high efficacy in younger age groups. CNBC’s Meg Tirrell reports on the emergency approval. Plus, Amazon nears a deal to buy MGM Studios for nearly $9 billion and Florida has become the first state to regulate how tech companies moderate speech online.

Progressive Democrats argue the U.S.‘s support for the Israelis should not be unlimited. This comes after the Biden administration approved a $735 million weapons sale to Israel. Eamon Dennis Ross, special assistant to President Obama and Middle East negotiator during the Clinton and George H.W. Bush administrations, joins to discuss the U.S. response to the conflict in Israel. Molly Hunter reports on new Covid rules in the United Kingdom as it loosens restrictions. Meanwhile, Meg Tirrell reports how some employers are making vaccines mandatory for employees in the United States. Plus, the Supreme Court has decided to hear a Mississippi abortion case that will, essentially, challenge Roe v. Wade. NBC’s Pete Williams reports.

The CDC and FDA have lifted the recommended pause on the use of the J&J vaccine. The committee found benefits of the vaccine outweighed the risks of the rare blood clots. Meg Tirrell reports. Dr. Peter Hotez, co-director of the Center for Vaccine Development at Texas Children’s Hospital, also discusses the J&J vaccine and says we need to work harder to get more conservatives vaccinated in order to reach herd immunity. Scott Cohn reports former Olympian and celebrity Caitlyn Jenner is launching a bid to run for California governor. This comes after people demanded a recall vote for current California Gov. Newsom. Hackers say they’ve hacked into an Apple manufacturing partner and stolen valuable blueprints. Now they’re threatening to leak the information to the public unless Apple pays them $50 million. Eamon Javers reports. Plus, Contessa Brewer reports on how VR technology is being used to train police officers.

How soon will we get a Covid-19 vaccine? Why is biotech moving airline stocks? And what can we learn from 1860s science?

If this pandemic plays out like a baseball game, former FDA Commissioner Scott Gottlieb says we're only in the second inning. He joins CNBC's Tyler Mathisen and Meg Tirrell to talk testing, vaccines, and what we're still learning about the virus.

Understanding the accuracy, efficacy and outcomes of COVID-19 tests and treatments. Former FDA Commissioner Dr. Scott Gottlieb joins CNBC's Senior Health and Science reporter Meg Tirrell for a deep dive into the various tests and treatments currently being employed and developed for COVID-19. This conversation is part of CNBC's “Healthy Returns: The Path Forward” series.

Steve sits down with expert reporter, Meg Tirrell, to get specific answers about the drugs that are first in line to cure us. The post CNBC's Meg Tirrell Answers The Questions Everyone's Asking About Cures And Treatments appeared first on Steve Pomeranz.

Meg Tirrell is a reporter with CNBC focusing on biotech and pharmaceuticals, and she joins us to discuss CNBC's new conference “Healthy Returns”. The conference brings together powerhouse minds from healthcare, business and tech; Meg will be right in the thick of it. Our conversation covers politics, the opioid epidemic, and how to ensure the patient voice is heard. A fascinating discussion of what is sure to be a truly unique event.